Back
Enlivex Therapeutics Stock Predictions
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
17
ENLV
Enlivex Therapeutics
Last Price:
1.06
Seasonality Move:
14.56%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Enlivex Therapeutics Stock Forecast
-
Is Enlivex Therapeutics Stock Undervalued?
The current Enlivex Therapeutics [ENLV] share price is $1.07. The Score for ENLV is 17, which is 66% below its historic median score of 50, and infers higher risk than normal. - ENLV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Enlivex Therapeutics Stock Go Up Next Year?
Data Unavailable
Enlivex Therapeutics Stock Rating
Data Unavailable
Enlivex Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Israel
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
enlivex.com
52-Week Data
52-Week High:
4.59
52-Week Low:
1.01
Prediction Charts
Market Cap:
22.9M
Price in USD:
1.07
Volume:
130.41K
Beta:
1.27
Technical Analysis
SMA50:
1.43
SMA100:
1.38
SMA200:
1.90
52-Wk Change:
-38.86%
Stock Predictions
-
Is Enlivex Therapeutics stock public?
Yes, Enlivex Therapeutics is a publicly traded company. -
What is the Enlivex Therapeutics stock quote today?
The Enlivex Therapeutics stock price is 1.07 USD today. -
How to buy Enlivex Therapeutics stock online?
You can buy Enlivex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-29 | 1.45 | 1.44 | 1.48 | 1.41 |
| Oct-30 | 1.47 | 1.38 | 1.47 | 1.36 |
| Oct-31 | 1.40 | 1.35 | 1.41 | 1.27 |
| Nov-1 | 1.35 | 1.36 | 1.41 | 1.30 |
| Nov-4 | 1.41 | 1.28 | 1.43 | 1.22 |
| Nov-5 | 1.29 | 1.29 | 1.32 | 1.24 |
| Nov-6 | 1.31 | 1.27 | 1.33 | 1.21 |
| Nov-7 | 1.27 | 1.27 | 1.31 | 1.21 |
| Nov-8 | 1.25 | 1.23 | 1.29 | 1.21 |
| Nov-11 | 1.27 | 1.19 | 1.27 | 1.15 |
| Nov-12 | 1.20 | 1.20 | 1.23 | 1.17 |
| Nov-13 | 1.21 | 1.17 | 1.21 | 1.13 |
| Nov-14 | 1.16 | 1.08 | 1.17 | 1.08 |
| Nov-15 | 1.09 | 1.07 | 1.10 | 1.01 |
Enlivex Therapeutics Earnings
Data Unavailable
Enlivex Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $0.10 per share.
* Enlivex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.